Draining HIV Viral Reservoirs: Abivax Prepares ABX464 Cure For Phase IIb

 
• By Sten Stovall

Abivax CEO outlines next moves after Phase IIa trial using ABX464 showed first proof in human of viral load reduction of hidden HIV reservoirs.

HIV virus
'Drain The Swamp': ABX464 May Improve recognition of HIV infected cells by the immune system. • Source: Shutterstock

More from Clinical Trials

More from R&D